WHO Model Prescribing Information: Drugs Used in HIV-Related Infections
(1999; 58 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Abrir esta carpeta y ver su contenidoOpportunistic infections
Abrir esta carpeta y ver su contenidoRespiratory disease
Abrir esta carpeta y ver su contenidoNeurological disorders
Abrir esta carpeta y ver su contenidoOpthalmological complications
Abrir esta carpeta y ver su contenidoFebrile illness
Abrir esta carpeta y ver su contenidoGastrointestinal tract/diarrhoeal disease
Abrir esta carpeta y ver su contenidoMucocutaneous and cutaneous eruptions
Cerrar esta carpetaDrugs
Ver el documentoAciclovir
Ver el documentoAlbendazole
Ver el documentoAmphotericin B
Ver el documentoAzithromycin
Ver el documentoBenzylpenicillins
Ver el documentoCalcium folinate
Ver el documentoCeftriaxone
Ver el documentoCiprofloxacin
Ver el documentoClarithromycin
Ver el documentoClindamycin
Ver el documentoCodeine
Ver el documentoDapsone
Ver el documentoFluconazole
Ver el documentoFlucytosine
Ver el documentoFoscarnet
Ver el documentoGanciclovir
Ver el documentoItraconazole
Ver el documentoKetoconazole
Ver el documentoNystatin
Ver el documentoPentamidine
Ver el documentoPrimaquine
Ver el documentoPyrimethamine
Ver el documentoRifabutin
Ver el documentoSulfadiazine
Ver el documentoSulfadoxine/Pyrimethamine (Fansidar)
Ver el documentoSulfamethoxazole/Trimethoprim (Cotrimoxazole)
Ver el documentoTrimethoprim
Ver el documentoBack Cover
 

Nystatin

Group: antifungal agent
Tablet, 500 000 IU[EDL]
Pessary, 100 000 IU [EDL]

General information

Nystatin is an antifungal polyene antibiotic derived from Streptomyces noursei. It is effective against infections caused by a wide range of yeasts and yeast-like fungi.

Clinical information

Uses

Treatment of oral and vaginal candidiasis.

Dosage and administration

Vaginal candidiasis:

100 000 - 1 000 000 IU as pessaries inserted high into the vagina nightly for at least 2 weeks.

Administration should be continued for 48 hours after clinical cure. Higher doses and longer period of treatment may be necessary in immunocompromised patients.

Oral candidiasis:

One tablet four times daily; tablets should be sucked, not swallowed, and retained in the mouth for as long as possible. Therapy should be continued for at least 48 hours after symptoms have resolved.

Contraindications and precautions

Treatment should be discontinued if symptoms of irritation or sensitization occur.

Use in pregnancy

Nystatin is poorly absorbed, if at all. It has been shown to be safe in pregnancy.

Adverse effects

Mild and transient nausea, vomiting and diarrhoea may occur after oral administration. Irritation rarely occurs after topical application.

Storage

Tablets should be stored in well-closed containers. Pessaries should be stored below 15°C in well-closed containers, protected from light.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012